KCNK17 and atrial fibrillation: Atrial K2P17.1 abundance is reduced in patients with HF or AF [21], and duration of atrial action potentials (AP) is prolonged in patients and animal models with HF [17,21], consistent with reduction of repolarizing K+ currents.